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ORIGINAL ARTICLE
Sentinel node localisation using pre-operative lymphoscintigraphy and
intraoperative gamma probe in early oral cavity cancer
Mubasher Ikram,1 Shabbir Akhtar,2 Maseeh-uz-Zaman,3 Montasir Junaid,4 Tariq Dhari,5 Zubair Ahmad,6 Riffat Hussain7

Abstract
Objectives: To assess the diagnostic value of sentinel lymph node localisation using pre-operative
lymphoscintigraphy and intra-operative gamma probe radio localisation in Pakistani patients suffering from early
stage squamous cell carcinoma of the oral cavity.
Methods: The prospective case series was conducted between September 2007 and April 2010 at the Aga Khan
University Hospital, Karachi. It comprised patients with T1and T2 oral cavity cancer with clinically and
radiologically negative neck. Pre-operative lymphoscintigraphy was performed one day before surgery and intraoperative gamma probe was used to detect sentinel node. Final histo-pathological evaluation was taken as the
gold standard.
Results: The study comprised 42 patients: 32(76%) males and 10(24%) females. The primary tumour site was
buccal mucosa in 25 (60%) patients, and tongue in 17 (40%). Sentinel lymph node was detected in 38 (90%)
patients.
On final histopathological identification, 7 (17%) patients had cancer in the neck nodes. In all patients with
metastasis, sentinel lymph node technique correctly identified the involved neck level. None of the patients
revealed metastasis in non-sentinel lymph nodes.
Conclusion: Evidence suggested the use of sentinel node biopsy in patients with head and neck squamous cell
carcinoma.
Keywords: Sentinel lymph node, Lymphoscintigraphy, Squamous cell carcinoma, Oral cavity. (JPMA 63: 976; 2013)

Introduction
Squamous cell carcinoma (SCC) is the most common
malignancy affecting the head and neck region. It
typically metastasizes into the regional cervical lymph
nodes before spreading to distant organs. The
involvement of lymph nodes by malignant cells is
strongly related to a poor prognosis, as the presence
of lymph node metastasis has shown to decrease
survival by 50%.1 The determination of nodal status in
the neck is, therefore, important and vital for proper
patient management. The current pre-operative
clinical methods, including radiographic techniques
like ultrasound, computed tomography (CT ) and
magnetic resonance imaging (MRI), although helpful,
are not confirmatory and often misdiagnose the
presence or absence of cervical nodal metastasis in
many patients.2
These techniques generally disregard nodes smaller than
10mm as suspicious. However, even smaller nodes can
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harbour micro-metastatic disease.3 To avoid missing
nodal metastasis and its associated poor prognosis,
elective neck dissection (END) is advocated for the
management of clinically node-negative (cN0)neck. This
approach has significantly improved regional recurrencefree survival and has lowered the incidence of distant
metastases.4 However, only in 30% clinically-negative
necks metastases is found after END,5 and 15% of
clinically-positive necks are in fact, tumour-negative.6
END, therefore, may be considered an overtreatment in
almost 70% of patients.
In order to avoid associated morbidities and cost of END,
a technique that precisely recognises disease in the CNO
neck is required. Much interest has arisen in the
technique of sentinel lymph node (SLN) mapping for
SCC of head and neck throughout the world.
Lymphoscintigraphy (LSG) is performed to identify the
first echelon node draining the lymph fluid from the
tumour region and find out if there is tumour deposit in
the node.
The goal of the current study was to assess the diagnostic
value of SLN localisation method, using pre-operative LSG
and intra-operative gamma probe radio localisation in
patients suffering from early stage SCC of oral cavity. To
J Pak Med Assoc

Sentinel node localisation using pre-operative lymphoscintigraphy and intraoperative gamma probe in early oral cavity cancer

the best of our knowledge, this is the first such study from
Pakistan.

Patients and Methods
The prospective case series spanned a period between
September 2007 and April 2010, and comprised 42 SLN
mapping procedures at the Aga Khan University Hospital,
Karachi. Institutional ethical committee approval and
informed consent from the patients were obtained prior
to the SLN procedure in all cases. A multi-disciplinary
team was formed which included head and neck
surgeons, nuclear physicians, histopathologists and
research staff. Further, University Research Council grant
was also obtained to decrease the financial burden of the
consenting patients.
The inclusion criterion was a clinically and
radiologically negative neck, as defined by physical
examination and radiological imaging by CT scans. All
patients previously treated by surgery or radiation
were excluded from the study. All the cases related to
T1 or T2 tumours of the oral cavity in cN0 patients and
were managed pre-operative LSG, intra-operative use
of gamma probe, and pathological evaluation, with a
follow-up of at least 2 years.
All the patients were admitted one day before surgery
and pre-operative LSG was performed on the day of the
admission. Following acquisition of the LSG image,
lymphoscintigraphic technique during surgery a gamma
probe was used and a unilateral or bilateral neck
dissection was performed.
Primary tumour site was anaesthetised with topical 10%
Xylocaine. Besides, 37 MBq (Mega Becquerel) of Tc-99m
Nano colloid (NanoColl, diameter <80 nm) was given in
four quadrants of primary lesion by the nuclear
physician. LSG images (anterior and both lateral) were
obtained at 15min, 1 hour and 18 hours after injection.
Visualized SLN were marked over the skin by an indelible
ink using a radioactive point source under gamma
camera. The thickness of overlying tissue >5 mm may
affect the detection rate, hence intra-operative detection
was also performed by placing the probe directly on the
lymph nodes.
The combination of dye-like Isosulfan blue dye and
nuclear imaging improves the sensitivity, and detection
rate, but this was not done in our study due to nonavailability of the dye in the country.
All cases involved intra-operative use of a gamma probe
detector. In oral cavity malignancy often the primary
tumour is very close giving a shine through effect with a
positive background, making it difficult to identify the
Vol. 63, No. 8, August 2013
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SLN, the primary tumour was first resected in all cases and
then hand-held gamma probe was used to detect activity
in cervical lymph nodes.
Sentinel nodes were labeled according to their anatomical
neck level and their radioactivity. All lymph nodes
accumulating activity were initially termed sentinel nodes.
A node was labeled as true sentinel node after final
histological results. After the removal of the sentinel node,
all patients underwent unilateral or bilateral neck
dissection, as dictated by the location of the primary
tumour.
Full pathological protocol was adapted by a senior
pathologist for histopathological exam Sentinel nodes
and neck dissection specimens were fixed in 10%
neutral buffered formalin and were bisected through
their longest axis after fixation. All nodes were
evaluated by a haematoxylin-eosin (H&E)-stained
multiple sections. Results of the histological
examination of the neck dissection specimens and SLNs
were compared.
After surgery, all patients were followed up in the clinic
every month for the 1st year and at 2 months thereafter.
Patients were up-staged according to final histopathology
of sentinel and non-sentinel neck nodes. Minimum
follow-up was for a period of 24 months.

Results
Of the 42 patients, 32(76%) were male and 10(24%) were
female. The mean age of all the patients was 52 ±7.5 years
with a range of 31-75 years. The primary tumour site was
buccal mucosa in 25(60%) patients and tongue in 17(40%)
patients. Tumour was confined to one side in 39(93%)
patients, whereas in 3(7%) patients with tongue
carcinoma it was crossing the midline. Clinically, 22(52%)
patients had T1 and 20(48%) patients had T2stage. The
drainage of radio colloid was identified in at least one SLN
in 38(90%) patients. A SLN could not be detected in
4(10%) patients.
On final histopathological identification, 7(17%)
patients had cancer in the neck nodes: 3(42.85%)
had T1 and 4 (57.14%) hadT2 primary tumours.
Metastasis was found at level I in 2(28.57%) patients;
level II in 2(28.57%); and level III in 3(42.85%)
patients. Overall, 7(17%) patients SLN technique
correctly identified the involved neck level. None of
the patients revealed metastasis in non-sentinel
lymph nodes.
In all the 4(9.5%) patients where a SLN was not detected,
no metastasis was found on final histopathological
examination (Table).
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Table: Stage and level of the nodes.
Serial
No

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42

T stage

1
2
2
1
1
2
1
2
1
2
2
1
2
2
1
1
1
2
1
1
2
1
2
1
2
1
2
2
1
1
2
1
2
2
2
1
1
2
1
2
1
1

Lymph node level
positive by gamma
probe (Sentinel node)

Lymph node level
positive on
final histology

I
II
II
II
III
I
I
II
I
II
II
III
II
I
I
III
I
I
I
II
II
I
I
III
I
III
I
I
II
I
I
I
II
I
III
II
III
I

II
II
I
III
I
III
III
-

Discussion
The prognosis of head and neck cancer patients depends
on final staging. The primary disease, regional and distant
metastases, has a powerful influence in reducing overall
survival rates.7 Oral cancers are locally invasive and surgery
can be curative if clear margins are achieved.8 Oral cancers
spread through lymphatic pathways to the cervical lymph
nodes. The presence of cancer metastasis in neck nodes is

the single most important bad prognostic factor,
decreasing overall 5-years survival from 82% to 53%.7
Traditionally, for the management of clinically and
radiologically negative neck, two options are available;
observation or elective neck dissection (END). The
incidence of regional metastases reported in literature
around 30% and the presence of regional disease is the
cause of the death of one in every two patients.9
The END is the gold standard in patients with higher than
20% risk of occult disease.3 But traditionally neck
dissection was associated with removal of relevant
normal structures of neck with significant post-operative
morbidity having impact, on the quality of life (QOL).
Modifications of neck dissection like Selective Neck
Dissection preserving non-lymphopathic structures for
the management of the N0 neck was introduced to
decrease the morbidity of more traditional modified
radical neck dissections.10
Morbidity associated with selective neck dissection is
definitely less than radical dissection, but there are still
quality effects, especially when bilateral dissection is
performed. Recent QOL studies have favoured sentinel
node biopsy over END.10
In search of less invasive procedures, SLN has
demonstrated usefulness in other types of cancer like
breast and melanoma.11,12 This has led to SLN biopsy
becoming a popular technique for determining whether
metastases is present in the first echelon of draining
lymph nodes and has allowed these patients to avoid
procedural morbidity while undergoing END for their
malignancies.13
Our result of SLN identification is comparable to other
studies reported in literature. The identification was 90%,
which is very similar to other comparable series.14-16 The
identification of SLN is far superior and quick in comparison
with cervical neck dissections. Identification of SLN and
attempt to assess the occult disease with fine needle
aspiration cytology, though thought to have the least
morbidity, was not successful as it does not detect occult
metastatic disease as the sample of the SLN is too small.17,18
In four of our patients, no sentinel node was detected.
One study 20 reported that this might be due to wrong
injection technique, injecting too deep into the tissue or
not close enough to the mucosa.19 Other reasons may be
that in-transit metastases blocked the drainage of the
radio colloid into the sentinel node.
In 7 patients with occult metastases, H&E staining was
sufficient to detect the metastases. Some studies have
J Pak Med Assoc
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recommended serial sectioning of the SLNs at intervals of
1-mm and immunohistochemical staining for keratin with
pancytokeratin to reveal occult micro metastases.16,20,21
A limitation of our study is that it relied on final histology
and not on the frozen section to detect the involvement
of a node. This is because the main aim of our study was
to find the accuracy of LSG. A separate study is needed to
assess the sensitivity and specificity of frozen section for
sentinel node detection.

7.

8.

9.

The approximate cost for each patient without frozen
section was Rs.6000. Surgeons intending to use this
modality should keep cost-effectiveness in their mind

10.

A study has suggested that serial sectioning,
immunohistochemistry, and molecular methods may
help to identify smaller metastatic deposits. H&E staining
with serial sectioning identifies one cancer cell among
10,000 normal cells. Immunohistochemistry identifies one
tumor cell amongst 100,000 normal cells. Reverse
transcriptase-polymerase chain reaction (RT-PCR) is the
most sensitive of them all.

11.

Conclusion
The study provides further weight to the argument in
favour of sentinel node biopsy in patients with head and
neck SCC, but it should be considered as an
investigational tool pending validation by larger
randomised clinical trials.
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